Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin54.8%-3.7pp53.5%-6.6pp51.4%-7.9pp59.4%-0.1pp58.5%-7.8pp
Efficiency
Asset turnover+0.1×+0.2×0.0×0.9×-0.1×0.8×-0.4×
Inventory turnover2.8×+0.3×2.4×+0.5×3.6×-5.8×1.8×-7.0×2.5×-5.9×
Liquidity
Current ratio1.2×-0.8×1.6×-0.5×1.6×+0.1×1.8×+0.4×+0.4×
Quick ratio0.9×-0.6×1.2×-0.1×1.2×-0.2×1.2×-0.1×1.4×0.0×
Cash ratio0.4×-0.2×0.7×-0.1×0.8×-0.2×0.7×-0.3×0.7×-0.4×
Leverage
Debt-to-equity-0.2×1.2×0.0×1.3×+1.1×1.3×+0.9×1.2×+0.9×
Debt-to-assets0.3×0.0×0.3×-0.1×0.3×+0.2×0.3×+0.1×0.4×+0.2×
Valuation
Market capitalization$930.79M+162%$453.48M+30.7%$582.75M+276%$364.45M+331%$348.09M+261%
Enterprise value$942.39M+156%$458.63M+26.7%$576.5M+315%$369.77M+416%$360.83M+326%
Price / sales10.7×+3.4×5.7×-3.2×8.3×+3.8×6.3×+3.6×7.2×+4.4×
Price / book31.2×+16.3×17.3×+3.1×25.2×+15.5×15.2×+8.9×14.2×+8.0×
EV / sales11.1×+3.3×5.7×-3.5×8.2×+4.2×6.4×+4.1×7.5×+5.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Eton Pharmaceuticals, Inc.'s profit margins?
Eton Pharmaceuticals, Inc. (ETON) runs a 54.8% gross margin and a -15.1% operating margin, with a -9.5% net margin.
Where do Eton Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Eton Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.